ARTIFICIAL INTELLIGENCE IS REVOLUTIONIZING PATHOLOGY
Data powered
pathology
Advanced pathology for preclinical research, clinical trials, and decision support
Pathology INTELLIGENCE
Advancing Research, Improving Patient Outcomes
What we do
Biopharma Services
Take advantage of our high quality histopathology research services to generate quantitative pathology end points.
imageDx
Access the the most advanced AI-powered digital assay pathology platform in the cloud.
Clinical Decision Support
Incorporate AI-powered pathology decision support tools to improve patient outcomes.
Pathology Powered By
DATA
Innovative Technology
Quantitative IHC
High quality immunohistochemistry (IHC) combined with whole slide imaging and cell-by-cell quantification to advance your research.
imageDx: NASH
Access the most advanced quantitative NASH and fibrosis data from your human or rodent liver samples.
Trusted By The World's Leading Scientists
Data powered pathology for advanced research & better patient care
News & Articles
Latest research, in the news, or at events.
Reveal Biosciences Joins the CellCarta Family
CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences MONTREAL, Canada, May 11th, 2021 / CNW – CellCarta, a global provider of precision
Reveal Biosciences Creates A New Artificial Intelligence Approach to Spatial Genomics in Partnership with QuantumCyte
The partnership paves way for the integration of AI-driven spatial genomics with a unique cloud-based platform (SAN DIEGO, Jan. 19, 2021) — Reveal Biosciences, Inc., a leader in AI
Reveal Biosciences’ AI-powered imageDx™ platform expedites pathology review of over 3,500 slides for COVID study
The universal demand to bring a COVID vaccine to market has expedited timelines in both preclinical and clinical research. While vaccine development efforts have been accelerated, traditional pathology evaluation
